1. Alnazer, M. 2014. Jordan’s advancement into the clinical market and it regulatory framework. Journal for Clinical Studies 6: 16–18.
2. Aroiuri, A., S. Al-Mahrouq, M. Al-Ghazawl, and D. Russmann. 2015. The evolving clinical research environment in Jordan. Regulatory Rapporteur 12: 16–21.
3. Conesa, S., Yadav, P. and Bader, R. 2009. Analysis of the Pharmaceutical Supply Chain in Jordan. A study funded by The World Bank under the MeTA initiative. Jordan.(
www.medicinestransparency.org/fileadmin/uploads/Documents/countries/Supply_Chain_Reports/MeTA_Jordan_Supply_Chain_Report.pdf
) accessed 23 Nov 2015.
4. Jordan Food & Drug Administration. 2001. Clinical research law. Available at:
http://www.jfda.jo/EN/Laws/LawInfo.aspx?id=507
. Accessed 11 Feb 2007.
5. Jordan Food and Drug Administration. 2011. Law No. 2 of clinical studies for the year 2011. Available at:
http://www.jfda.jo/Default.aspx
.